CHEMO PHARMA LABORATORIES LTD. - 506365 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of SEBI (DP), Regulations, 2018 for the Quarter Ended June 30, 202402-07-2024
02-07-2024
CHEMO PHARMA LABORATORIES LTD. - 506365 - Closure of Trading Window
Intimation of Trading Window closure28-06-2024
CHEMO PHARMA LABORATORIES LTD. - 506365 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding issue of Duplicate Share Certificate under Reg. 39(3) of SEBI (LODR) Regulation, 201510-06-2024
CHEMO PHARMA LABORATORIES LTD. - 506365 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Submission of Newspaper Advertisement of Audited Financial Results for the Quarter and Year Ended March 31, 2024 of the Company28-05-2024
CHEMO PHARMA LABORATORIES LTD. - 506365 - Appointment Of M/S. Sarda Soni Associates LLP As An Internal Auditor For The Financial Year 2024-2025
Appointment of M/S Sarda Soni Associates LLP as an Internal Auditor for the Financial Year 2024-202527-05-2024
CHEMO PHARMA LABORATORIES LTD. - 506365 - Audited Financial Results Of The Company For The Quarter And Financial Year Ended March 31, 2024
Audited Financial Results of the Company for the Quarter and Year Ended March 31, 202427-05-2024
CHEMO PHARMA LABORATORIES LTD. - 506365 - Board Meeting Outcome for Outcome Of The Board Meeting Held On Monday, May 27, 2024
Outcome Of The Board Meeting Held On Monday, May 27, 202427-05-2024
CHEMO PHARMA LABORATORIES LTD. - 506365 - Declaration Of Non-Applicability Of Regulation 23(9) Of SEBI (LODR) Regulation, 2015
Declaration of Non-Applicability of Regulation 23(9) of SEBI (LODR) Regulation, 2015 for the half year ended March 31, 202415-05-2024
CHEMO PHARMA LABORATORIES LTD. - 506365 - Board Meeting Intimation for Board Meeting To Be Held On Monday, May 27, 2024
CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2024 ,inter alia, to consider and approve the following business: 1. To consider and approve the Audited Financial Results for the quarter and year ended March 31, 2024 along with the Auditor's Report thereon. 2. To consider appointment of M/s Sarda Soni & Associates as Internal Auditor of the Company for the financial year 2024-2510-05-2024
CHEMO PHARMA LABORATORIES LTD. - 506365 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding issue of Dublicate Share Certificate under Regulation 39(3) of SEBI (LODR) Regulations, 201507-05-2024